查找临床试验
已按「间皮瘤」检索，对应国际通用词 mesothelioma
共找到 12 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 00:19，每 5 分钟自动同步PTC-Guided Therapy for Peritoneal Mesothelioma
China
年龄 18 Years – 85 Years
Beijing Tsinghua Chang Gung Hospital
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
United States、Australia、Brazil、Canada、China 等 12 国
年龄 18 Years – 不限
AstraZeneca
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
United States、China、Japan
年龄 18 Years – 不限
Genmab
Efficacy and Safety of Ivonescimab Plus Pemetrexed and Platinum-Based Chemotherapy in Advanced Malignant Pleural Mesothelioma
China
年龄 18 Years – 75 Years
Ruijin Hospital
GPC3/Mesothelin-CAR-γδT Cells Against Cancers
China
年龄 18 Years – 75 Years
Second Affiliated Hospital of Guangzhou Medical University
Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural Mesothelioma
China
年龄 18 Months – 75 Months
The First Hospital of Jilin University
Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM
China
年龄 18 Years – 不限
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
APG-2449 in Patients With Advanced Solid Tumors
China
年龄 18 Years – 不限
Ascentage Pharma Group Inc.
Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma
China
年龄 18 Years – 75 Years
Beijing Biotech
Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
United States、China
年龄 18 Years – 不限
InSilico Medicine Hong Kong Limited
A Study of MT027 in Patients with Pleural Malignant Tumors
China
年龄 18 Years – 不限
Suzhou Maximum Bio-tech Co., Ltd.
First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma
China
年龄 18 Years – 不限
Cancer Institute and Hospital, Chinese Academy of Medical Sciences